Analysis of tissue biopsies from melanoma patients that, according to the American Joint Committee on Cancer, spanned stages I to IV, revealed also neo-expression of CEACAM1 in around 80% of biopsies [68,72,74]. This evidence concerns the gene CEACAM1 and melanoma.